Trial
NCT05003908
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Diabetes
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
The Foundation for Orthopaedics and Regenerative Medicine
Collaborators
—
Condition
Diabetes
Intervention
AlloRx
Why stopped
Due to lack of efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-04-08